ClearPoint-13169-Final-Logo-CMYK jpg.jpg
ClearPoint Neuro Reports Fourth Quarter and Full Year 2022 Preliminary Revenue Results and Guidance for Full Year 2023 Revenue
January 11, 2023 08:00 ET | ClearPoint Neuro, Inc.
SOLANA BEACH, Calif., Jan. 11, 2023 (GLOBE NEWSWIRE) -- ClearPoint Neuro, Inc. (Nasdaq: CLPT) (the “Company”), a global therapy-enabling platform company providing navigation and delivery to the...
The ClearPoint Prism™ Neuro Laser Therapy System
ClearPoint Neuro Announces First Patient Enrolled in Glioblastoma Trial Using ClearPoint Prism™ Neuro Laser Therapy System at Skåne University Hospital in Sweden
December 12, 2022 09:15 ET | ClearPoint Neuro, Inc.
SOLANA BEACH, Calif., Dec. 12, 2022 (GLOBE NEWSWIRE) -- ClearPoint Neuro, Inc. (Nasdaq: CLPT) (the “Company”), a global therapy-enabling platform company providing navigation and delivery to the...
ClearPoint-13169-Final-Logo-CMYK jpg.jpg
ClearPoint Neuro to Present at Upcoming Investor Conferences
November 09, 2022 09:25 ET | ClearPoint Neuro, Inc.
SOLANA BEACH, Calif., Nov. 09, 2022 (GLOBE NEWSWIRE) -- ClearPoint Neuro, Inc. (Nasdaq: CLPT) (the “Company”), a global therapy-enabling platform company providing navigation and delivery to the...
ClearPoint-13169-Final-Logo-CMYK jpg.jpg
ClearPoint Neuro Reports Third Quarter 2022 Results
November 08, 2022 16:05 ET | ClearPoint Neuro, Inc.
SOLANA BEACH, Calif., Nov. 08, 2022 (GLOBE NEWSWIRE) -- ClearPoint Neuro, Inc. (Nasdaq: CLPT) (the “Company”), a global therapy-enabling platform company providing navigation and delivery to the...
ClearPoint-13169-Final-Logo-CMYK jpg.jpg
ClearPoint Neuro to Announce Third Quarter 2022 Results November 8, 2022
October 26, 2022 16:05 ET | ClearPoint Neuro, Inc.
SOLANA BEACH, Calif., Oct. 26, 2022 (GLOBE NEWSWIRE) -- ClearPoint Neuro, Inc. (Nasdaq: CLPT) (the “Company”), a global therapy-enabling platform company providing navigation and delivery to the...
ClearPoint Prism™ Neuro Laser Therapy System
ClearPoint Neuro Announces FDA Clearance for ClearPoint Prism™ Neuro Laser Therapy System
September 23, 2022 02:45 ET | ClearPoint Neuro, Inc.
SOLANA BEACH, Calif., Sept. 22, 2022 (GLOBE NEWSWIRE) -- ClearPoint Neuro, Inc. (Nasdaq: CLPT) (the “Company”), a global therapy-enabling platform company providing navigation and delivery to the...
Mazin Sabra
ClearPoint Neuro Announces Appointment of Mazin Sabra as Chief Operating Officer
September 20, 2022 16:05 ET | ClearPoint Neuro, Inc.
SOLANA BEACH, Calif., Sept. 20, 2022 (GLOBE NEWSWIRE) -- ClearPoint Neuro, Inc. (Nasdaq: CLPT) (the “Company”), a global therapy-enabling platform company providing navigation and delivery to the...
Software 2.1 1.TargetStep-ReviewLayoutwithVOI
ClearPoint Neuro Announces FDA Clearance for Software Version 2.1
September 19, 2022 16:13 ET | ClearPoint Neuro, Inc.
SOLANA BEACH, Calif., Sept. 19, 2022 (GLOBE NEWSWIRE) -- ClearPoint Neuro, Inc. (Nasdaq: CLPT) (the “Company”), a global therapy-enabling platform company providing navigation and delivery to the...
ClearPoint-13169-Final-Logo-CMYK jpg.jpg
ClearPoint Neuro Reports Second Quarter 2022 Results
August 09, 2022 16:15 ET | ClearPoint Neuro, Inc.
SOLANA BEACH, Calif., Aug. 09, 2022 (GLOBE NEWSWIRE) -- ClearPoint Neuro, Inc. (Nasdaq: CLPT) (the “Company”), a global therapy-enabling platform company providing navigation and delivery to the...
ClearPoint-13169-Final-Logo-CMYK jpg.jpg
ClearPoint Neuro Announces FDA Clearance for ClearPoint Maestro™ Brain Model
August 09, 2022 16:05 ET | ClearPoint Neuro, Inc.
SOLANA BEACH, Calif., Aug. 09, 2022 (GLOBE NEWSWIRE) -- ClearPoint Neuro, Inc. (Nasdaq: CLPT) (the “Company”), a global therapy-enabling platform company providing navigation and delivery to the...